Abstract .uk

One might expect that therapies based on cardiomyogenic stem cells also pose increased risk of rupture and ventricular dilation, wherein infarcts could be more likely to show mechanical failure when healing is shifted towards regeneration and away from expeditious formation of a mechanically strong scar. Bone marrow-derived cells, which have limited cardiomyogenic potential, may be beneficial ... ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download